Recombinant TSH Wins Approval for Remnant Ablation: Patients gain alternative to withdrawal.

Last month's approval of recombinant thyroid-stimulating hormone for remnant ablation will give thyroid cancer patients what experts agree is a more tolerable and similarly effective alternative to treatment with thyroid hormone withdrawal.